These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 23594254)

  • 1. Interesting snapshot in a dual chamber pacemaker: what's the mechanism?
    Almehairi M; Abdollah H; Brennan FJ; Baranchuk A
    Pacing Clin Electrophysiol; 2013 Oct; 36(10):1306-7. PubMed ID: 23594254
    [No Abstract]   [Full Text] [Related]  

  • 2. Loss of biventricular pacing and inappropriate therapy by a cardiac resynchronization implantable defibrillator.
    Pap R; Klausz G; Balázs T; Sághy L
    Pacing Clin Electrophysiol; 2013 Aug; 36(8):1030-1. PubMed ID: 23305526
    [No Abstract]   [Full Text] [Related]  

  • 3. Conventional and biventricular pacing in patients with first-degree atrioventricular block.
    Barold SS; Herweg B
    Europace; 2012 Oct; 14(10):1414-9. PubMed ID: 22516061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pacemaker lead overcoiling: the overcoil-retraction phenomenon.
    Modi S; Barker D; Rao A
    Heart; 2011 Oct; 97(19):1627. PubMed ID: 21730262
    [No Abstract]   [Full Text] [Related]  

  • 5. Ventricular activation sequence during left ventricular pacing promotes QRS complex oversensing in the atrial channel.
    Jastrzebski M
    Pacing Clin Electrophysiol; 2011 Dec; 34(12):1682-6. PubMed ID: 21954967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leadless pacing: The old with the new.
    Wilson DG; Yue A; Roberts PR; Morgan JM
    Int J Cardiol; 2016 Jan; 203():407-8. PubMed ID: 26539965
    [No Abstract]   [Full Text] [Related]  

  • 7. Unusual atrial-paced tachycardia after pacemaker implantation: what is the mechanism?
    Viswanathan MN; Tseng ZH; Goldschlager N; Lee BK
    Heart Rhythm; 2007 Jun; 4(6):800-2. PubMed ID: 17556209
    [No Abstract]   [Full Text] [Related]  

  • 8. Right ventricular lead positioning does not influence the benefits of cardiac resynchronization therapy in patients with heart failure and atrial fibrillation.
    Rönn F; Kesek M; Karp K; Henein M; Jensen SM
    Europace; 2011 Dec; 13(12):1747-52. PubMed ID: 21712261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of rate control during atrial fibrillation on the proarrhythmic and antiarrhythmic effects of biventricular pacing.
    Gu X; Zhu Y; Sun L; Zhang Y; Cao K; Cheng J
    Int J Cardiol; 2012 Aug; 159(2):162-3. PubMed ID: 22704864
    [No Abstract]   [Full Text] [Related]  

  • 10. Interatrial conduction correlates with optimal atrioventricular timing in cardiac resynchronization therapy devices.
    Levin V; Razavi M; Coll R; Coles JA; Sambelashvili A
    Pacing Clin Electrophysiol; 2011 Apr; 34(4):443-9. PubMed ID: 21208227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent Failure of Automated Threshold Evaluation: What is the Mechanism?
    Kalra V; Foreman L; Bhakta D
    Pacing Clin Electrophysiol; 2016 Aug; 39(8):870-2. PubMed ID: 27062280
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiac resynchronization: what's next?
    Leclercq C
    Arch Cardiovasc Dis; 2012; 105(6-7):335-7. PubMed ID: 22800717
    [No Abstract]   [Full Text] [Related]  

  • 13. Direct left ventricular endocardial pacing: an alternative when traditional resynchronization via coronary sinus is not feasible or effective.
    Moriña-Vázquez P; Roa-Garrido J; Fernández-Gómez JM; Venegas-Gamero J; Pichardo RB; Carranza MH
    Pacing Clin Electrophysiol; 2013 Jun; 36(6):699-706. PubMed ID: 23521222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous coronary vein angioplasty for severe spasm of the posterolateral vein during bi-ventricular pacing.
    Kapoor A; Kumar S; Batra A
    J Invasive Cardiol; 2011 Jul; 23(7):E170-2. PubMed ID: 21725134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transverse sternotomy for atrioventricular and biventricular pacing lead implantations.
    Sansone F; Ceresa F; Patanè F
    Int J Cardiol; 2016 Apr; 208():58-9. PubMed ID: 26828381
    [No Abstract]   [Full Text] [Related]  

  • 16. Take heart: gone but not forgotten?
    Fox DJ; Gula LJ; Subbiah RN; Tischenko A; Klein GJ; Krahn AD; Yee RK; Skanes AC
    J Cardiovasc Electrophysiol; 2008 Apr; 19(4):438-9. PubMed ID: 18298514
    [No Abstract]   [Full Text] [Related]  

  • 17. Heart rates in cardiac resynchronization: the art of optimal device programming.
    Maass AH; van Veldhuisen DJ
    Europace; 2011 Feb; 13(2):157-8. PubMed ID: 21186228
    [No Abstract]   [Full Text] [Related]  

  • 18. Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing triple-site cardiac resynchronization therapy: a substudy of TRUST CRT randomized trial.
    Lenarczyk R; Kowalski O; Sredniawa B; Pruszkowska-Skrzep P; Mazurek M; Jędrzejczyk-Patej E; Woźniak A; Pluta S; Głowacki J; Kalarus Z
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1228-36. PubMed ID: 22651239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac resynchronization therapy or sequential pacing in failing Mustard?
    Morani G; Luciani GB; Manica A; Prioli MA; Franceschini L; Tomei R; Vassanelli C
    J Electrocardiol; 2011; 44(2):285-8. PubMed ID: 20832821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Worsening heart failure as the main manifestation of neglected complete extrusion of a cardiac resynchronization therapy pacemaker.
    Vassilikos VP; Mantziari AA; Stavropoulos G; Styliadis IH
    Cardiology; 2010; 117(4):243-5. PubMed ID: 21228592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.